Author Correction: The current landscape of nucleic acid therapeutics

Jayesh A Kulkarni^#^{1

2

3}, Dominik Witzigmann^#^{2

3

4}, Sarah B Thomson¹, Sam Chen⁵, Blair R Leavitt¹, Pieter R Cullis^{2

4}, Roy van der Meel⁶

Affiliations

¹ Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
² NanoMedicines Innovation Network, Vancouver, British Columbia, Canada.
³ NanoVation Therapeutics, Vancouver, British Columbia, Canada.
⁴ Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
⁵ Integrated Nanotherapeutics, Vancouver, British Columbia, Canada.
⁶ Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands. r.v.d.meel@tue.nl.

^# Contributed equally.

Published Erratum

Jayesh A Kulkarni et al. Nat Nanotechnol. 2021 Jul.

. 2021 Jul;16(7):841.

doi: 10.1038/s41565-021-00937-w.

Jayesh A Kulkarni^#^{1

2

3}, Dominik Witzigmann^#^{2

3

4}, Sarah B Thomson¹, Sam Chen⁵, Blair R Leavitt¹, Pieter R Cullis^{2

4}, Roy van der Meel⁶

¹ Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
² NanoMedicines Innovation Network, Vancouver, British Columbia, Canada.
³ NanoVation Therapeutics, Vancouver, British Columbia, Canada.
⁴ Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
⁵ Integrated Nanotherapeutics, Vancouver, British Columbia, Canada.
⁶ Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands. r.v.d.meel@tue.nl.

^# Contributed equally.

No abstract available

Erratum for

The current landscape of nucleic acid therapeutics.
Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, van der Meel R. Kulkarni JA, et al. Nat Nanotechnol. 2021 Jun;16(6):630-643. doi: 10.1038/s41565-021-00898-0. Epub 2021 May 31. Nat Nanotechnol. 2021. PMID: 34059811 Review.